Stereotactic body radiation therapy for oligometastases

Expert Review of Anticancer Therapy

Volumn 9, Issue 5, 2009, Pages 621-635

  Lo, Simon S ^a   Fakiris, Achilles J ^b   Teh, Bin S ^c   Cardenes, Higinia R ^b   Henderson, Mark A ^b   Forquer, Jeffrey A ^b   Papiez, Lech ^e   McGarry, Ronald C ^d   Wang, Jian Z ^a   Li, Kaile ^a   Mayr, Nina A ^a   Timmerman, Robert D ^e  

^a OHIO STATE UNIVERSITY   (United States)

^b INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^c HOUSTON METHODIST HOSPITAL   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Body; Oligometastases; Radiation therapy; Stereotactic

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 2; OXALIPLATIN; PACLITAXEL;

BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER SURVIVAL; COLORECTAL CARCINOMA; CYBERKNIFE; ESOPHAGITIS; ESOPHAGUS STRICTURE; EXTERNAL BEAM RADIOTHERAPY; HEART DISEASE; HEMOPTYSIS; HEMORRHAGIC GASTRITIS; HUMAN; KIDNEY CARCINOMA; LIVER METASTASIS; LIVER RESECTION; LIVER TOXICITY; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG TOXICITY; METASTASIS; METASTASIS POTENTIAL; NAUSEA; NEPHRECTOMY; OVERALL SURVIVAL; PATIENT SAFETY; PATIENT SELECTION; PLEURA EFFUSION; PNEUMONIA; RADIATION DOSE; REVIEW; SPINAL CORD DISEASE; SPINAL CORD METASTASIS; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL RATE; SURVIVAL TIME; VERTEBRA FRACTURE; BRAIN TUMOR; LIVER TUMOR; LUNG TUMOR; PATHOLOGY; RADIOSURGERY; SPINAL CORD TUMOR;

BRAIN NEOPLASMS; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; RADIOSURGERY; SPINAL NEOPLASMS;

EID: 68149124336     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/ERA.09.15     Document Type: Review

References (74)

1. The International Registry of Lung Metastases. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J. Thorac. Cardiovasc. Surg. 113(1), 37-49 (1997).
2. Hellman S, Weichselbaum RR. Oligometastases. J. Clin. Oncol. 13(1), 8-10 (1995).
3. Mehta N, Mauer AM, Hellman S et al. Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment. Int. J. Oncol. 25(6), 1677-1683 (2004).
4. Fong Y, Cohen AM, Fortner JG et al. Liver resection for colorectal metastases. J. Clin. Oncol. 15(3), 938-946 (1997).
5. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann. Surg. 230(3), 309-318 (1999).
6. Miller G, Biernacki P, Kemeny NE et al. Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. J. Am. Coll. Surg. 205(2), 231-238 (2007).
7. Shah SA, Haddad R, Al-Sukhni W et al. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J. Am. Coll. Surg. 202(3), 468-475 (2006).
8. Patchell RA, Tibbs PA, Regine WF et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 366(9486), 643-648 (2005).
9. Lo SS, Fakiris AJ, Papiez L et al. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer. Expert Rev. Anticancer Ther. 8(1), 87-98 (2008).
10. Lo SS, Cardenes HR, Teh BS et al. Stereotactic body radiation therapy for nonpulmonary primary tumors. Expert Rev. Anticancer Ther. 8(12), 1939-1951 (2008).
11. Chang BK, Timmerman RD. Stereotactic body radiation therapy: a comprehensive review. Am. J. Clin. Oncol. 30(6), 637-644 (2007).
12. Park C, Papiez L, Zhang S, Story M, Timmerman RD. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 70(3), 847-852 (2008).
13. Wang JZ, Mayr NA, Yuh WTC. A generalized linear - qudratic formula for high-dose-rate brachytherapy and radiosurgery. Int. J. Radiat. Oncol. Biol. Phys. 69(3 Suppl.), S619-S620 (2007).
14. Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol. 34(6), 861-870 (1995).
15. Uematsu M, Shioda A, Tahara K et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer 82(6), 1062-1070 (1998).
16. Nakagawa K, Aoki Y, Tago M, Terahara A, Ohtomo K. Megavoltage CT-assisted stereotactic radiosurgery for thoracic tumors: original research in the treatment of thoracic neoplasms. Int. J. Radiat. Oncol. Biol. Phys. 48(2), 449-457 (2000).
17. Wulf J, Hadinger U, Oppitz U, Thiele W, Ness-Dourdoumas R. Flentje M. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther. Onkol. 177(12), 645-655 (2001).
18. Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int. J. Radiat. Oncol. Biol. Phys. 60(1), 186-196 (2004).
19. Hof H, Hoess A, Oetzel D, Debus J, Herfarth K. Stereotactic single-dose radiotherapy of lung metastases. Strahlenther. Onkol. 183(12), 673-678 (2007).
20. Lee SW, Choi EK, Park HJ et al. Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung Cancer 40(3), 309-315 (2003).
21. Okunieff P, Petersen AL, Philip A et al. Stereotactic body radiation therapy (SBRT) for lung metastases. Acta Oncol. 45(7), 808-817 (2006).
22. Hara R, Itami J, Kondo T et al. Stereotactic single high dose irradiation of lung tumors under respiratory gating. Radiother. Oncol. 63(2), 159-163 (2002).
23. Nagata Y, Negoro Y, Aoki T et al. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int. J. Radiat. Oncol. Biol. Phys. 52(4), 1041-1046 (2002).
24. Norihisa Y, Nagata Y, Takayama K et al. Stereotactic body radiotherapy for oligometastatic lung tumors. Int. J. Radiat. Oncol. Biol. Phys. 72(2), 398-403 (2008).
25. Ernst-Stecken A, Lambrecht U, Mueller R, Sauer R, Grabenbauer G. Hypofractionated stereotactic radiotherapy for primary and secondary intrapulmonary tumors: first results of a Phase I/II study. Strahlenther. Onkol. 182(12), 696-702 (2006).
26. Whyte RI, Crownover R, Murphy MJ et al. Stereotactic radiosurgery for lung tumors: preliminary report of a Phase I trial. Ann. Thorac. Surg. 75(4), 1097-1101 (2003).
27. Le QT, Loo BW, Ho A et al. Results of a Phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J. Thorac. Oncol. 1(8), 802-809 (2006).
28. Kavanagh BD, McGarry RC, Timmerman RD. Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases. Semin. Radiat. Oncol. 16(2), 77-84 (2006).
29. Blomgren H, Lax I, Goranson H et al. Radiosurgery for tumors in the body: clinical experience using a new method. J. Radiosurg. 1(1), 63-74 (1998).
30. Sato M, Uematsu M, Yamamoto F. Feasiblity of frameless stereotactic high-dose radiaiton therapy for primary and metastatic liver cancer. J. Radiosurg. 1, 233-238 (1998).
31. Wada H, Takai Y, Nemoto K, Yamada S. Univariate analysis of factors correlated with tumor control probability of three-dimensional conformal hypofractionated high-dose radiotherapy for small pulmonary or hepatic tumors. Int. J. Radiat. Oncol. Biol. Phys. 58(4), 1114-1120 (2004).
32. Herfarth KK, Debus J, Lohr F et al. Stereotactic single-dose radiation therapy of liver tumors: results of a Phase I/II trial. J. Clin. Oncol. 19(1), 164-170 (2001).
33. Katz AW, Carey-Sampson M, Muhs AG, Milano MT, Schell MC, Okunieff P. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int. J. Radiat. Oncol. Biol. Phys. 67(3), 793-798 (2007).
34. Gunven P, Blomgren H, Lax I, Levitt SH. Curative stereotactic body radiotherapy for liver malignancy. Med. Oncol. (2008)
35. Mendez Romero A, Wunderink W, Hussain SM et al. Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase I-II study. Acta Oncol, 45(7), 831-837 (2006).
36. Schefter TE, Kavanagh BD, Timmerman RD, Cardenes HR, Baron A, Gaspar LE. A Phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int. J. Radiat. Oncol. Biol. Phys. 62(5), 1371-1378 (2005).
37. Kavanagh BD, Schefter TE, Cardenes HR et al. Interim analysis of a prospective Phase I/II trial of SBRT for liver metastases. Acta Oncol. 45(7), 848-855 (2006).
38. Bone Pain Trial Working Party. 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Radiother. Oncol. 52(2), 111-121 (1999).
39. Price P, Hoskin PJ, Easton D, Austin D, Palmer SG, Yarnold JR. Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother. Oncol. 6(4), 247-255 (1986).
40. Steenland E, Leer JW, van Houwelingen H et al. The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother. Oncol. 52(2), 101-109 (1999).
41. Chow E, Harris K, Fan G, Tsao M, Sze WM. Palliative radiotherapy trials for bone metastases: a systematic review. J. Clin. Oncol. 25(11), 1423-1436 (2007).
42. Ryu S, Fang Yin F, Rock J et al. Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis. Cancer 97(8), 2013-2018 (2003).
43. Ryu S, Rock J, Rosenblum M, Kim JH. Patterns of failure after single-dose radiosurgery for spinal metastasis. J. Neurosurg. 101(Suppl. 3), 402-405 (2004).
44. Milker-Zabel S, Zabel A, Thilmann C, Schlegel W, Wannenmacher M, Debus J. Clinical results of retreatment of vertebral bone metastases by stereotactic conformal radiotherapy and intensity-modulated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 55(1), 162-167 (2003).
45. Hamilton AJ, Lulu BA, Fosmire H, Stea B, Cassady JR. Preliminary clinical experience with linear accelerator-based spinal stereotactic radiosurgery. Neurosurgery 36(2), 311-319 (1995).
46. Mahan SL, Ramsey CR, Scaperoth DD, Chase DJ, Byrne TE. Evaluation of image-guided helical tomotherapy for the retreatment of spinal metastasis. Int. J. Radiat. Oncol. Biol. Phys. 63(5), 1576-1583 (2005).
47. Rock JP, Ryu S, Shukairy MS et al. Postoperative radiosurgery for malignant spinal tumors. Neurosurgery 58(5), 891-898 (2006).
48. Gerszten PC, Germanwala A, Burton SA, Welch WC, Ozhasoglu C, Vogel WJ. Combination kyphoplasty and spinal radiosurgery: a new treatment paradigm for pathological fractures. J. Neurosurg. Spine 3(4), 296-301 (2005).
49. Gerszten PC, Burton SA, Ozhasoglu C, Welch WC. Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine 32(2), 193-199 (2007).
50. Gibbs IC, Kamnerdsupaphon P, Ryu MR et al. Image-guided robotic radiosurgery for spinal metastases. Radiother. Oncol. 82(2), 185-190 (2007).
51. Yamada Y, Lovelock DM, Yenice KM et al. Multifractionated image-guided and stereotactic intensity-modulated radiotherapy of paraspinal tumors: a preliminary report. Int. J. Radiat. Oncol. Biol. Phys. 62(1), 53-61 (2005).
52. Chang EL, Shiu AS, Mendel E et al. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J. Neurosurg. Spine 7(2), 151-160 (2007).
53. Sahgal A, Chuang C, Larson D. Proximity of spinous/paraspinous radiosurgery metastatic targets to the spinal cord versus risk of local failure. Int. J. Radiat. Oncol. Biol. Phys. 69, S243 (2007).
54. Gerszten PC, Burton SA, Ozhasoglu C et al. Stereotactic radiosurgery for spinal metastases from renal cell carcinoma. J. Neurosurg. Spine 3(4), 288-295 (2005).
55. Gerszten PC, Burton SA, Quinn AE, Agarwala SS, Kirkwood JM. Radiosurgery for the treatment of spinal melanoma metastases. Stereotact. Funct. Neurosurg. 83(5-6), 213-221 (2005).
56. Gerszten PC, Burton SA, Welch WC et al. Single-fraction radiosurgery for the treatment of spinal breast metastases. Cancer 104(10), 2244-2254 (2005).
57. Sahgal A, Larson DA, Chang EL. Stereotactic body radiosurgery for spinal metastases: a critical review. Int. J. Radiat. Oncol. Biol. Phys. 71(3), 652-665 (2008).
58. Chang EL, Shiu AS, Lii MF et al. Phase I clinical evaluation of near-simultaneous computed tomographic image-guided stereotactic body radiotherapy for spinal metastases. Int. J. Radiat. Oncol. Biol. Phys. 59(5), 1288-1294 (2004).
59. Cerfolio RJ, Allen MS, Deschamps C et al. Pulmonary resection of metastatic renal cell carcinoma. Ann. Thorac. Surg. 57(2), 339-344 (1994).
60. Fourquier P, Regnard JF, Rea S, Levi JF, Levasseur P. Lung meastases of renal cell carcinoma: results of surgical resection. Eur. J. Cardiothorac. Surg. 11(1), 17-21 (1997).
61. Lo SS, Chang EL, Suh JH. Stereotactic radiosurgery with and without whole-brain radiotherapy for newly diagnosed brain metastases. Expert Rev. Neurother. 5(4), 487-495 (2005).
62. Brown PD, Brown CA, Pollock BE, Gorman DA, Foote RL. Stereotactic radiosurgery for patients with "radioresistant" brain metastases. Neurosurgery 62(Suppl. 2), 790-801 (2008).
63. Chang EL, Selek U, Hassenbusch SJ 3rd et al. Outcome variation among "radioresistant" brain metastases treated with stereotactic radiosurgery. Neurosurgery 56(5), 936-945 (2005).
64. Teh BS, Bloch C, Paulino AC et al. Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery. Clin. Genitourin. Cancer 5(5), 334-337 (2007).
65. Wersall PJ, Blomgren H, Lax I et al. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother. Oncol. 77(1), 88-95 (2005).
66. Svedman C, Sandstrom P, Pisa P et al. A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma. Acta Oncol. 45(7), 870-875 (2006).
67. Hoyer M, Roed H, Traberg Hansen A et al. Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol. 45(7), 823-830 (2006).
68. Salama JK, Chmura SJ, Mehta N et al. An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease. Clin. Cancer Res. 14(16), 5255-5259 (2008).
69. Milano MT, Katz AW, Muhs AG et al. A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions. Cancer 112(3), 650-658 (2008).
70. McGarry RC, Papiez L, Williams M, Whitford T, Timmerman RD. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study. Int. J. Radiat. Oncol. Biol. Phys. 63(4), 1010-1015 (2005).
71. Timmerman R, McGarry R, Yiannoutsos C et al. Excessive toxicity when treating central tumors in a Phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J. Clin. Oncol. 24(30), 4833-4839 (2006).
72. Ryu S, Jin JY, Jin R et al. Partial volume tolerance of the spinal cord and complications of single-dose radiosurgery. Cancer 109(3), 628-636 (2007).
73. Laufer I, Rose P, Lis E, Bilsky MH, Yamada Y. An analysis of risk factors for vertebral body fracture following high-dose single-fraction image-guided intensity modulated radiotherapy (IG IMRT) of spinal metastases. Int. J. Radiat. Oncol. Biol. Phys. 72(1 Suppl.), S52 (2008).
74. McCammon R, Schefter TE, Gaspar LE, Zaemisch R, Gravdahl D, Kavanagh B. Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 73(1), 112-118 (2009).